Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience

Impact of Intravenous Administration of Voriconazole in Critically Ill Patients with Impaired Renal Function

(2014) F. Álvarez-Lerma et al.   JOURNAL OF CHEMOTHERAPY

Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients

(2011) Peter F. Troke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetic Evaluation with External Validation and Bayesian Estimator of Voriconazole in Liver Transplant Recipients

(2011) Kelong Han et al.   CLINICAL PHARMACOKINETICS

Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers

(2011) SeungHwan Lee et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Human Tissue Distribution of Voriconazole

(2010) Stefan Weiler et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bioavailability and Population Pharmacokinetics of Voriconazole in Lung Transplant Recipients

(2010) K. Han et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis

(2010) John W. Baddley et al.   CLINICAL INFECTIOUS DISEASES

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

(2010) C. Cordonnier et al.   HAEMATOLOGICA

Clinician Ordering Practices for Voriconazole Therapeutic Drug Monitoring: Experiences of a Referral Laboratory

(2010) Spiros Miyakis et al.   THERAPEUTIC DRUG MONITORING

Serial Plasma Voriconazole Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation

(2009) S. M. Trifilio et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Voriconazole concentrations and outcome of invasive fungal infections

(2009) S. Miyakis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia

(2009) Antonio Torres et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

(2009) L. Pagano et al.   HAEMATOLOGICA

Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders

(2009) Koki Ueda et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Voriconazole plasma monitoring

(2008) A C Pasqualotto et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

(2008) Brahm H. Segal et al.   CLINICAL INFECTIOUS DISEASES

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES